Search Results - "Gustavo Citera"

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial by Schiff, Michael, Weinblatt, Michael E, Valente, Robert, van der Heijde, Désirée, Citera, Gustavo, Elegbe, Ayanbola, Maldonado, Michael, Fleischmann, Roy

“…To compare over 2 years the safety, efficacy and radiographic outcomes of subcutaneous abatacept versus adalimumab, in combination with methotrexate (MTX), in…”
Get more information

Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study by Weinblatt, Michael E., Schiff, Michael, Valente, Robert, van der Heijde, Désirée, Citera, Gustavo, Zhao, Cathy, Maldonado, Michael, Fleischmann, Roy

“…Objective There is a need for comparative studies to provide evidence‐based treatment guidance for biologic agents in rheumatoid arthritis (RA). Therefore,…”
Get full text

Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial by Dougados, Maxime, Heijde, Désirée, Sieper, Joachim, Braun, Jürgen, Maksymowych, Walter P., Citera, Gustavo, Miceli‐Richard, Corinne, Wei, James Cheng‐Chung, Pedersen, Ron, Bonin, Randi, Rahman, Mahboob U., Logeart, Isabelle, Wajdula, Joseph, Koenig, Andrew S., Vlahos, Bonnie, Alvarez, Daniel, Bukowski, Jack F.

“…Objective To assess the efficacy of etanercept in the treatment of early active nonsteroidal antiinflammatory drug (NSAID)–refractory nonradiographic axial…”
Get full text

SASDAS: a practical tool to measure disease activity in axSpa patients. Comments on “a prospective study of novel disease activity indices for ankylosing spondylitis” by Capelunsik, Dafne, Schneeberger, Emilce E., Citera, Gustavo

Get full text

Acceso al tratamiento con drogas modificadoras de la enfermedad biológicas o sintéticas dirigidas en pacientes con artritis reumatoidea by Citera, Gustavo

“…En los últimos años el tratamiento de la artritis reumatoidea (AR) ha mejorado sustancialmente, no solo por la aparición de nuevas medicaciones, sino…”
Get full text

Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study by Maksymowych, Walter P, Dougados, Maxime, van der Heijde, Désirée, Sieper, Joachim, Braun, Jürgen, Citera, Gustavo, Van den Bosch, Filip, Logeart, Isabelle, Wajdula, Joseph, Jones, Heather, Marshall, Lisa, Bonin, Randi, Pedersen, Ron, Vlahos, Bonnie, Kotak, Sameer, Bukowski, Jack F

“…To evaluate the efficacy and safety of etanercept (ETN) after 48 weeks in patients with early active non-radiographic axial spondyloarthritis (nr-axSpA)…”
Get more information

The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study by Emery, Paul, Tanaka, Yoshiya, Bykerk, Vivian P, Bingham, Clifton O, Huizinga, Thomas W J, Citera, Gustavo, Huang, Kuan-Hsiang Gary, Wu, Chun, Connolly, Sean E, Elbez, Yedid, Wong, Robert, Lozenski, Karissa, Fleischmann, Roy

“…AVERT-2 (a phase IIIb, two-stage study) evaluated abatacept + methotrexate versus methotrexate alone, in methotrexate-naive, anti-citrullinated protein…”
Get full text

Effects of Long‐Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104‐Week Results From a Randomized, Placebo‐Controlled Study by Dougados, Maxime, van der Heijde, Désirée, Sieper, Joachim, Braun, Jürgen, Citera, Gustavo, Lenaerts, Jan, van den Bosch, Filip, Wei, James Cheng‐Chung, Pedersen, Ron, Bonin, Randi, Jones, Heather, Marshall, Lisa, Logeart, Isabelle, Vlahos, Bonnie, Bukowski, Jack F., Maksymowych, Walter P.

“…Objective To evaluate the long‐term clinical and imaging efficacy of etanercept in patients with early, active nonradiographic axial spondyloarthritis (SpA)…”
Get full text

Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria by Hernán, Maldonado Ficco, Gustavo, Citera, José Antonio, Maldonado Cocco

“…The aim of this study is to determine the prevalence of psoriatic arthritis (PsA) according to CASPAR criteria, ASAS peripheral and axial SpA criteria, and New…”
Get full text

Patient Preferences for Biologic Agents in Rheumatoid Arthritis: A Discrete-Choice Experiment by Augustovski, Federico, MD, MSc, PhD, Beratarrechea, Andrea, MD, MSc, Irazola, Vilma, MD, MSc, Rubinstein, Fernando, MD, MSc, Tesolin, Pablo, MD, Gonzalez, Juan, Lencina, Verónica, MD, Scolnik, Marina, MD, Waimann, Christian, MD, Navarta, David, MD, Citera, Gustavo, MD, Soriano, Enrique R., MD, MSc

“…Abstract Objectives To assess patients’ preferences for rheumatoid-arthritis treatments with biologic agents using a discrete-choice experiment. Methods A…”
Get full text

Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials by Citera, Gustavo, Jain, Rakesh, Irazoque, Fedra, Madariaga, Hugo, Gruben, David, Wang, Lisy, Stockert, Lori, Santana, Karina, Ebrahim, Abbas, Ponce de Leon, Dario

“…Introduction The aim of our work is to assess the prevalence of probable major depressive disorder and/or probable generalized anxiety disorder (pMDD/pGAD) in…”
Get full text

Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis by Citera, Gustavo, Bautista-Molano, Wilson, Peláez-Ballestas, Ingris, Azevedo, Valderilio F, Perich, Risto A, Méndez-Rodríguez, José A, Cutri, Mariel S, Borlenghi, Cecilia E

“…Large epidemiologic and clinical estimates of spondyloarthritis (SpA) in Latin America are not available. In this narrative review, our goal was to…”
Get full text

A useful tool to assess quality of LIFE in rheumatoid arthritis patients that does not require a license: QOL-RA II by Isnardi, Carolina Ayelen, Schneeberger, Emilce Edith, Capelusnik, Dafne, de los Ángeles Correa, María, Lim, Romina, Hu, María, Tapia, María Janina, Kerzberg, Eduardo, Blanco, Eliana, Benavidez, Federico Luján, Gonzales Lucero, Luciana, Barbaglia, Ana Lucía, Bazzarelli, Marcela, Ficco, Hernán Maldonado, Pérez, Silvana, Hartvig, Claudia, Salcedo, Mariana, Citera, Gustavo

“…To validate the Quality of Life-Rheumatoid Arthritis Scale II (QOL-RA II) in an Argentinean cohort of patients with rheumatoid arthritis (RA). Patients ≥…”
Get full text

Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis by Emery, Paul, Tanaka, Yoshiya, Bykerk, Vivian P., Huizinga, Thomas W. J., Citera, Gustavo, Bingham, Clifton O., Banerjee, Subhashis, Soule, Benjamin P., Nys, Marleen, Connolly, Sean E., Lozenski, Karissa L., Zhuo, Joe, Wong, Robert, Huang, Kuan-Hsiang Gary, Fleischmann, Roy

“…Introduction One target of rheumatoid arthritis (RA) treatment is to achieve early sustained remission; over the long term, patients in sustained remission…”
Get full text

Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era by Di Sanzo, Lorenzo, Scrivo, Rossana, Soriano, Enrique Roberto, Citera, Gustavo, Mysler, Eduardo, Wei, James Cheng-Chung, Ríos, Mario Humberto Cardiel

Get full text

Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis by Pugliesi, Alisson, de Oliveira, Amanda Borges, Oliveira, Ana Beatrice, Xavier, Ricardo, da Mota, Licia Maria Henrique, Bertolo, Manoel Barros, Gonzalez-Gay, Miguel Angel, Citera, Gustavo, de Carvalho, Luiz Sergio Fernandes

“…Our aim was to compare the efficacy of rituximab, tocilizumab, and abatacept in individuals with rheumatoid arthritis (RA) refractory to treatments with MTX or…”
Get full text

Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy by Cerda, Osvaldo Luis, de Los Angeles Correa, María, Granel, Amelia, Marcos, Ana Ines, Giraldo, Claudia, Rillo, Oscar, Schneeberger, Emilce Edith, Citera, Gustavo

“…The blockade of inflammatory mediators produced by biological therapies is associated with an increased risk of opportunistic infections, as for example…”
Get full text

Reporte de pacientes con espondiloartritis y arteritis de Takayasu en Argentina: ¿asociación causal o casual? by Ceccato, Federico, Schneeberger, Emilce E., Scolnik, Marina, Citera, Gustavo, Castel del Cid, Cecilia, Albiero, Juan Alejandro

“…Introducción: tanto las espondiloartritis (EspA) como la arteritis de Takayasu (TAK) son enfermedades infrecuentes, y su asociación es aún más rara. Objetivos:…”
Get full text

“Treat to Persist”, una profundización del “Treat to Target” by Gustavo Citera, Eduardo Mysler, Enrique R. Soriano

“…El tratamiento de la artritis reumatoidea (AR), ha evolucionado considerablemente en los últimos años, resultando en una mejoría notable en la capacidad…”
Get full text

Epidemiology of Spondyloarthritis in Argentina by Buschiazzo, Emilio, MD, Maldonado-Cocco, Jose A., MD, Arturi, Pablo, MD, Citera, Gustavo, MD, Berman, Alberto, MD, Nitsche, Alejandro, MD, Rillo, Oscar L., MD

“…Abstract Introduction Spondyloarthritis (SpA) includes a group of diseases that share immunogenetic, clinical and radiologic findings, with a particular…”
Get full text